The president of France's drug industry trade association (LEEM), Christian Lajoux, has signed with France's Health Minister, Xavier Bertrand, a Code of Practice for the drug industry for use in the continuous medical training sector. In a statement, the LEEM noted that the Code would ensure the respect of three fundamental principles: the scientific quality of course content, transparency of funding and evaluation of participants' training.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze